This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CS-003
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Decipher Genomic Classifier
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
AUA 2024
APCCC 2024
EAU 2024
All Conferences
View All
PCF
UroToday Home
Conference Highlights
SUO 2017
SUO 2017
Testicular Cancer
Kidney Cancer
Penile Cancer
Bladder Cancer
Prostate Cancer
SUO 2017 Bladder Cancer
Viewing 41-60 of 64 articles
SUO 2017: Post-TUR Mitomycin C Debate: Should it be Standard of Care?
SUO 2017: Is Gemcitabine the Answer?
SUO 2017: Preoperative Multiplex Nomogram For Prediction Of high-risk non-organ confined Upper-Tract Urothelial Carcinoma
SUO 2017: Thermo Reversible Hydrogel Based Delivery MitoGelâ„¢ - Upper Tract Urothelial Carcinoma
SUO 2017: Post-Transurethral Resection Intravesical Mitomycin C Debate
SUO 2017: Muscle-invasive Bladder Cancer Patients Who Did Not Receive Radical Cystectomy: Treatment Decisions, Alternative Treatments, And Opportunities For Care Improvement
SUO 2017: Currently Approved Immunotherapy for Bladder Cancer
SUO 2017: Complications Following Radical Cystectomy And Urinary Diversion Surgery
SUO 2017: Cancer And All-cause Mortality In Bladder Cancer Patients Undergoing Radical Cystectomy: Development And Validation Of A Nomogram For Treatment Decision-making
SUO 2017: Novel Use Of Pre-operative CT-measured Adipose Tissue Indices To Predict Postoperative And Survival Outcomes Among Patients Undergoing Radical Cystectomy
SUO 2017: Clinical Utility of Next Generation Sequencing in Urothelial Bladder Cancer
SUO 2017: Bladder Cancer: Comparative Analysis of National Cancer Database with Propensity Score Weighting
SUO 2017: Cost-effectiveness Analysis Of A Biomarker-based Approach To Select Patients With Muscle-invasive Bladder Cancer For Neoadjuvant Chemotherapy
SUO 2017: Effect of Blue-Light Cystoscopy of Recurrence/Progression Rates for Vesigenurtacel-L (Hs-410) with BCG in Patients with NMIBC
SUO 2017: Assessment of Blue Light Flexible Cystoscopy with Cysview on Patient Reported Outcomes
SUO 2017: Prognostic Significance of EZH2 Expression in Upper Tract Urothelial Carcinoma
SUO 2017: Impact of Post-Treatment Psychiatric Illness on Survival Outcomes Following Muscle-Invasive Bladder Cancer Patients
SUO 2017: Differences Between De Novo vs Secondary Upper Tract Urothelial Carcinoma
SUO 2017: Natural History of Indeterminate Pulmonary Nodules in Radical Cystectomy Patients
SUO 2017: Discriminative Ability of Commonly Used Indices to Predict Adverse Outcomes After Radical Cystectomy
1
2
3
4
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free